Table 1

Demographic profile and baseline characteristics of patients in the two treatment groups

CharacteristicAADI (n=56)AGV (n=70)P value
Frequency%Frequency%
Age, mean±SD (minimum–maximum), years7.81±5.40 (0.19–18)8.97±5.20 (0.55–18)
Gender0.425
 Male3257.13550.0
 Female2442.93550.0
Glaucoma type0.120
 Primary congenital glaucoma3358.92840.0
 Glaucoma associated with non-acquired ocular anomalies35.4710.0
 Glaucoma associated with acquired condition47.1912.9
 Glaucoma following cataract surgery1323.22535.7
 Other35.411.4
Eye0.842
 Right2951.83550.0
 Left2748.23550.0
Lens0.016
 Phakic3460.72637.1
 Pseudophakic1119.61521.4
 Aphakic1119.62941.4
Central corneal thickness653.33±131.88 (305–1000)712.38±145.76 (526–1100)0.053
Number of previous glaucoma surgeries2.18±1.73 (0–10)2.31±1.23 (1–6)0.608
Intraocular pressure32.18±8.17 (15–54)33.07±7.83 (15–55)0.538
Topical AGM3.25±1.31 (0–5)3.24±1.06 (0–4)0.973
Oral AGM0.550
 Yes610.71014.3
 No5089.36085.7
Visual acuity (logMAR)1.09±0.661.21±0.790.50
  • AADI, Aurolab aqueous drainage implant; AGM, antiglaucoma medication; AGV, Ahmed glaucoma valve; logMAR, Logarithm of the Minimum Angle of Resolution.